The topology of plasminogen binding and activation on the surface of human breast cancer cells
Open Access
- 11 September 2001
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 85 (6) , 909-916
- https://doi.org/10.1054/bjoc.2001.2022
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Assembly of Urokinase Receptor-Mediated Plasminogen Activation Complexes Involves Direct, Non-Active-Site Interactions between Urokinase and PlasminogenBiochemistry, 1998
- Loss of Cell Viability Dramatically Elevates Cell Surface Plasminogen Binding and ActivationExperimental Cell Research, 1998
- The human ENO1 gene product (recombinant human α-enolase) displays characteristics required for a plasminogen binding proteinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1997
- ENDOTHELIAL CELL SURFACE ACTIN SERVES AS A BINDING SITE FOR PLASMINOGEN, TISSUE PLASMINOGEN ACTIVATOR AND LIPOPROTEIN(a)British Journal of Haematology, 1996
- Conformational changes in plasminogen, their effect on activation, and the agents that modulate activation rates — a reviewFibrinolysis, 1996
- Plasma carboxypeptidases as regulators of the plasminogen system.Journal of Clinical Investigation, 1995
- The Role of an Enolase‐Related Molecule in Plasminogen Binding to CellsEuropean Journal of Biochemistry, 1995
- Actin Stimulates Plasmin Generation by Tissue and Urokinase-Type Plasminogen ActivatorsArchives of Biochemistry and Biophysics, 1993
- Stopped‐flow fluorescence kinetic studies of Glu‐plasminogen Conformational changes triggered by AH‐site ligand bindingFEBS Letters, 1991
- A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.The Journal of cell biology, 1985